PolyNovo has licensed its materialls to Biomet, Medtronics and...

PolyNovo has licensed its materialls to Biomet, Medtronics and Smith and Nephew. In addition PolyNovo has partnerships with Dr. Tony Moore for the development of dermal fillers and with Dr. John Greenwood for burn treatment and wound management.

Some of these ventures have been in place for two years.

The news that will make this stock soar is overdue: news of clinical trials of one or more of the products that have been in the pre-clinical stage for a long long time.

While it is aanybody's guess when this might happen, it could happen at any time.

When it does, six cents a share will be in the rear view mirror within days.